Transcatheter aortic valve implantation (TAVI): Current perspectives;Perkutane Aortenklappenimplantation (TAVI): Aktueller Stand

Herz

Volumn 40, Issue 5, 2015, Pages 742-751

  Gaede, Luise ^a   Möllmann, Helge ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

Aortic valve replacement, percutaneous; Aortic valve stenosis; High risk patients; Prosthetic valves; Quality of life

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIAC SURGEON; CARDIOLOGIST; CONSERVATIVE TREATMENT; DECISION MAKING; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; MORTALITY; QUALITY OF LIFE; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTA VALVE; AORTIC VALVE STENOSIS; DEVICES; EVIDENCE BASED MEDICINE; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; MINIMALLY INVASIVE SURGERY; PROCEDURES; TREATMENT OUTCOME;

AORTIC VALVE; AORTIC VALVE STENOSIS; EVIDENCE-BASED MEDICINE; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MINIMALLY INVASIVE SURGICAL PROCEDURES; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84939270839     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-015-4328-x     Document Type: Article

References (55)

1. Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L, Tuzcu M, Webb J, Fontana G, Makkar R, Brown D, Block P, Guyton R, Pichard A, Bavaria J, Herrmann H, Douglas P, Peterson J, Akin J, Anderson W, Wand D, Pocock S, for the PTI (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607
2. Smith C, Leon M, Mack M, Miller D, Moses J, Svnesson L, Tuzcu E, Webb J, Fontana G, Makkar R, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani V, Corso P, Pichard A, Bavaria J, Herrmann H, Akin J, Anderson W, Wang D, PS for the PTI (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198. (http://scholar.google.com/scholar?. Zugegriffen: 3. Aug. 2013)
3. Adams DH, Popma JJ, Reardon MJ (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 371(10):967–968. doi:10.1056/NEJMc1408396
4. Cribier A, Eltchaninoff H, Bash A et al (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24):3006–3008. doi:10.1161/01.CIR.0000047200.36165.B8
5. Kuck K-H, Eggebrecht H, Figulla HR et al (2014) Qualitätskriterien zur Durchführung der transvaskulären Aortenklappenimplantation (TAVI). Kardiol 9(1):11–26. doi:10.1007/s12181-014-0622-8
6. Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9–13
7. Di Giammarco G, Rabozzi R, Chiappini B, Tamagnini G (2010) Absolute and relative risk prediction in patients candidate to isolated aortic valve replacement: should we change our mind? Eur J Cardiothorac Surg 37(2):255–260. doi:10.1016/j.ejcts.2009.08.025
8. Osswald BR, Gegouskov V, Badowski-Zyla D et al (2009) Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 30(1):74–80. doi:10.1093/eurheartj/ehn523
9. Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89(3):787–793.e2. doi:10.1016/j.athoracsur.2009.11.032
10. Rosenhek R, Iung B, Tornos P et al (2012) ESC working group on valvular heart disease position paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 33(7):822–828. doi:10.1093/eurheartj/ehr061
11. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM (2005) Generic, simple risk stratification model for heart valve surgery. Circulation 112(2):224–231. doi:10.1161/CIRCULATIONAHA.104.515049
12. Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43(5):971–977. doi:10.1093/ejcts/ezt114
13. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ (2008) Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 135(1):180–187. doi:10.1016/j.jtcvs.2007.09.011
14. Détaint D, Lepage L, Himbert D et al (2009) Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2(9):821–827. doi:10.1016/j.jcin.2009.07.003
15. Sherif MA, Abdel-Wahab M, Stöcker B et al (2010) Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol 56(20):1623–1629. doi:10.1016/j.jacc.2010.06.035
16. Moss RR, Ivens E, Pasupati S et al (2008) Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc Imaging 1(1):15–24. doi:10.1016/j.jcmg.2007.09.004
17. Kempfert J, Van Linden A, Lehmkuhl L et al (2012) Aortic annulus sizing: echocardiographic versus computed tomography derived measurements in comparison with direct surgical sizing. Eur J Cardiothorac Surg 42(4):627–633. doi:10.1093/ejcts/ezs064
18. Wood DA, Tops LF, Mayo JR et al (2009) Role of multislice computed tomography in transcatheter aortic valve replacement. Am J Cardiol 103(9):1295–1301. doi:10.1016/j.amjcard.2009.01.034
19. Tops LF, Wood DA, Delgado V et al (2008) noninvasive evaluation of the aortic root with multislice computed tomography. implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 1(3):321–330. doi:10.1016/j.jcmg.2007.12.006
20. Schultz CJ, Moelker A, Piazza N et al (2010) Three dimensional evaluation of the aortic annulus using multislice computer tomography: are manufacturer’s guidelines for sizing for percutaneous aortic valve replacement helpful? Eur Heart J 31(7):849–856. doi:10.1093/eurheartj/ehp534
21. Mack MJ, Leon MB, Smith CR et al (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. (15)60308-7 (6736(Partner 1):1–8)
22. Kapadia SR, Leon MB, Makkar RR et al (2015) 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. doi:10.1016/S0140-6736(15)60290-2 (6736(Partner 1):1–7)
23. Mohr FW, Holzhey D, Möllmann H et al (2014) The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg 46(5):808–816. doi:10.1093/ejcts/ezu290 (0(March 2013):1–9)
24. Möllmann H (2015) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis AQUA registry. Clin Res Cardiol 104(Suppl 1):1934
25. Popma JJ, Adams DH, Reardon MJ et al (2014) Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63(19):1972–1981. doi:10.1016/j.jacc.2014.02.556
26. Thyregod HGH, Steinbrüchel DA, Ihlemann N et al (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers Nordic Aortic Valve Intervention (NOTION) randomized clinical trial. J Am Coll Cardiol. doi:10.1016/j.jacc.2015.03.014
27. Abdel-Wahab M, Mehilli J, Frerker C et al (2014) Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement. JAMA 311(15):1503. doi:10.1001/jama.2014.3316
28. Kempfert J, Möllmann H, Walther T (2012) Symetis ACURATE TA valve. EuroIntervention 8(Suppl Q):102–109. doi:10.4244/EIJV8SQA19
29. Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A (2013) Symetis ACURATE TFTM aortic bioprosthesis. EuroIntervention 9(Suppl):107–111. doi:10.4244/EIJV9SSA22
30. Schofer J, Colombo A, Klugmann S et al (2014) Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol 63(8):763–768. doi:10.1016/j.jacc.2013.10.013
31. Sündermann SH, Holzhey D, Bleiziffer S, Treede H (2013) Medtronic Engager TM bioprosthesis for transapical transcatheter aortic valve implantation. EuroIntervention 9:97–101. doi:10.4244/EIJV9SSA19
32. Sinning JM, Werner N, Nickenig G, Grube E (2012) Medtronic CoreValve Evolut valve. EuroIntervention 8(Suppl Q):94–96. doi:10.4244/EIJV8SQA17
33. Treede H, Rastan A, Ferrari M, Ensminger S, Figulla H-R, Mohr F-W (2012) JenaValve. EuroIntervention 8(Q):Q88–Q93. doi:10.4244/EIJV8SQA16
34. Meredith IT, Hood KL, Haratani N, Allocco DJ, Dawkins KD (2012) Boston Scientific Lotus valve. EuroIntervention 8(Suppl Q):70–74. doi:10.4244/EIJV8SQA12
35. Manoharan G, Spence MS, Rodés-Cabau J, Webb JG (2012) St Jude Medical Portico valve. EuroIntervention 8(Suppl Q):97–101. doi:10.4244/EIJV8SQA18
36. Binder RK, Rodés-Cabau J, Wood DA, Webb JG (2012) Edwards SAPIEN 3 valve. EuroIntervention 8(Suppl Q):83–87. doi:10.4244/EIJV8SQA15
37. Webb J, Gerosa G, Lefèvre T et al (2014) Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol 64(21):2235–2243. doi:10.1016/j.jacc.2014.09.026
38. Zhang Y, Pyxaras SA, Wolf A, Schmitz T, Naber CK (2015) Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: device success, thirty-day safety, and mortality. Catheter Cardiovasc Interv 85(7):1217–1225. doi:10.1002/ccd.25831 (00(August 2014):n/a-n/a)
39. Kempfert J, Meyer A, Kim W-K et al (2015) Comparison of two valve systems for transapical aortic valve implantation: a propensity score-matched analysis. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv042 (1–7)
40. Mollmann H, Kim W-K, Kempfert J, Walther T, Hamm C (2015) Complications of transcatheter aortic valve implantation (TAVI): how to avoid and treat them. Heart 101(11):900–908. doi:10.1136/heartjnl-2013-304708
41. Sinning J-M, Vasa-Nicotera M, Chin D et al (2013) Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol 62(1):11–20. doi:10.1016/j.jacc.2013.02.088
42. Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 35(24):1588–1598. doi:10.1093/eurheartj/eht381
43. Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. doi:10.1016/j.jacc.2015.03.034
44. Tamburino C, Capodanno D, Ramondo A et al (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3):299–308. doi:10.1161/CIRCULATIONAHA.110.946533
45. Abdel-wahab M, Richardt G (2014) Selection of TAVI prostheses: do we really have the CHOICE? EuroIntervention 10:28–34
46. Meredith Am IT, Walters DL, Dumonteil N et al (2014) Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol 64(13):1339–1348. doi:10.1016/j.jacc.2014.05.067
47. Van Linden AB, Walther T et al (2013) Rescue valve-in-valve implantations in second generation transapical transcatheter aortic valve prostheses. Clin Res Cardiol 102(3):241–243. doi:10.1007/s00392-012-0520-7
48. Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH (2012) Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 23(4):391–397. doi:10.1111/j.1540-8167.2011.02211.x
49. Jilaihawi H, Chin D, Vasa-Nicotera M et al (2009) Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 157(5):860–866. doi:10.1016/j.ahj.2009.02.016
50. Bleiziffer S, Ruge H, Hörer J et al (2010) Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 3(5):524–530. doi:10.1016/j.jcin.2010.01.017
51. Nazif TM, Dizon JM, Hahn RT et al (2015) Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement. JACC Cardiovasc Interv 8(1):60–69. doi:10.1016/j.jcin.2014.07.022
52. Siontis GCM, Jüni P, Pilgrim T et al (2014) Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR. J Am Coll Cardiol 64(2):129–140. doi:10.1016/j.jacc.2014.04.033
53. Urena M, Rodés-Cabau J (2015) Permanent pacemaker implantation following transcatheter aortic valve replacement. JACC Cardiovasc Interv 8(1):70–73. doi:10.1016/j.jcin.2014.09.010
54. Kappetein AP, Head SJ, Généreux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60(15):1438–1454. doi:10.1016/j.jacc.2012.09.001
55. Schymik G, Wurth A, Bramlage P et al (2014) Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis. Circ Cardiovasc Interv 8(1):e000761–e000761. doi:10.1161/CIRCINTERVENTIONS.113.000761